Cargando…

Telomere Attrition in Induced Pluripotent Stem Cell-Derived Neurons From ALS/FTD-Related C9ORF72 Repeat Expansion Carriers

The GGGGCC (G4C2) repeat expansion in C9ORF72 is the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Dysregulated DNA damage response and the generation of reactive oxygen species (ROS) have been postulated as major drivers of toxicity in C9ORF72 p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robinson, Hayley, Ali, Sk Imran, Diaz-Hernandez, Martha Elena, Lopez-Gonzalez, Rodrigo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234284/ https://www.ncbi.nlm.nih.gov/pubmed/35769259 http://dx.doi.org/10.3389/fcell.2022.874323

Ejemplares similares

CRISPR interference to evaluate modifiers of C9ORF72-mediated toxicity in FTD
por: Pickles, Sarah, et al.
Publicado: (2023)

The Phenotype of the C9ORF72 Expansion Carriers According to Revised Criteria for bvFTD
por: Solje, Eino, et al.
Publicado: (2015)

A familial FTD associated with C9orf72 repeat expansion and dysplastic gangliocytoma
por: Kero, Mia, et al.
Publicado: (2013)

Oligonucleotide-Based Therapy for FTD/ALS Caused by the C9orf72 Repeat Expansion: A Perspective
por: Fernandes, Stephanie A., et al.
Publicado: (2013)

The Role of Dipeptide Repeats in C9ORF72-Related ALS-FTD
por: Freibaum, Brian D., et al.
Publicado: (2017)

Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene
por: van Blitterswijk, Marka, et al.
Publicado: (2014)

Genetic counseling for FTD/ALS caused by the C9ORF72 hexanucleotide expansion
por: Fong, Jamie C, et al.
Publicado: (2012)

Emerging Perspectives on Dipeptide Repeat Proteins in C9ORF72 ALS/FTD
por: Schmitz, Alexander, et al.
Publicado: (2021)

Implementation of an antibody characterization procedure and application to the major ALS/FTD disease gene C9ORF72
por: Laflamme, Carl, et al.
Publicado: (2019)

A new inducible transgenic mouse model for C9orf72-associated GGGGCC repeat expansion supports a gain-of-function mechanism in C9orf72-associated ALS and FTD
por: Hukema, Renate K, et al.
Publicado: (2014)

Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat Expansion
por: De Vocht, Joke, et al.
Publicado: (2020)

Unraveling the Role of RNA Mediated Toxicity of C9orf72 Repeats in C9-FTD/ALS
por: Kumar, Vijay, et al.
Publicado: (2017)

Nuclear export and translation of circular repeat-containing intronic RNA in C9ORF72-ALS/FTD
por: Wang, Shaopeng, et al.
Publicado: (2021)

Gyrification abnormalities in presymptomatic c9orf72 expansion carriers
por: Caverzasi, Eduardo, et al.
Publicado: (2019)

Modeling the C9ORF72 repeat expansion mutation using human induced pluripotent stem cells
por: Selvaraj, Bhuvaneish T., et al.
Publicado: (2017)

Retraction Note to: A new inducible transgenic mouse model for C9orf72-associated GGGGCC repeat expansion supports a gain-of-function mechanism in C9orf72-associated ALS and FTD
por: Hukema, Renate K., et al.
Publicado: (2016)

Disease Mechanisms and Therapeutic Approaches in C9orf72 ALS-FTD
por: Mayl, Keith, et al.
Publicado: (2021)

Breakdown of the central synapses in C9orf72-linked ALS/FTD
por: Ghaffari, Layla T., et al.
Publicado: (2022)

Retention of hexanucleotide repeat-containing intron in C9orf72 mRNA: implications for the pathogenesis of ALS/FTD
por: Niblock, Michael, et al.
Publicado: (2016)

Topology of a G-quadruplex DNA formed by C9orf72 hexanucleotide repeats associated with ALS and FTD
por: Zhou, Bo, et al.
Publicado: (2015)

Repeat‐associated non‐AUG translation in C9orf72‐ALS/FTD is driven by neuronal excitation and stress
por: Westergard, Thomas, et al.
Publicado: (2019)

Toxic expanded GGGGCC repeat transcription is mediated by the PAF1 complex in C9orf72-associated FTD.
por: Goodman, Lindsey D., et al.
Publicado: (2019)

Age-related penetrance of the C9orf72 repeat expansion
por: Murphy, Natalie A., et al.
Publicado: (2017)

Network degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers
por: Lee, Suzee E., et al.
Publicado: (2016)

Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit
por: Sattler, Rita, et al.
Publicado: (2023)

CRISPR/Cas9-mediated excision of ALS/FTD-causing hexanucleotide repeat expansion in C9ORF72 rescues major disease mechanisms in vivo and in vitro
por: Meijboom, Katharina E., et al.
Publicado: (2022)

Structure of the C9orf72 Arf GAP complex haploinsufficient in ALS and FTD
por: Su, Ming-Yuan, et al.
Publicado: (2020)

Pathological assessments for the presence of hexanucleotide repeat expansions in C9ORF72 in Alzheimer’s disease
por: Davidson, Yvonne S, et al.
Publicado: (2013)

Emerging roles of interferon-stimulated gene-15 in age-related telomere attrition, the DNA damage response, and cardiovascular disease
por: González-Amor, María, et al.
Publicado: (2023)

CUG initiation and frameshifting enable production of dipeptide repeat proteins from ALS/FTD C9ORF72 transcripts
por: Tabet, Ricardos, et al.
Publicado: (2018)

Translation of dipeptide repeat proteins in C9ORF72 ALS/FTD through unique and redundant AUG initiation codons
por: Sonobe, Yoshifumi, et al.
Publicado: (2023)

A Tale of Two States: Pluripotency Regulation of Telomeres
por: Novo, Clara Lopes
Publicado: (2021)

Homozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia
por: Fratta, Pietro, et al.
Publicado: (2013)

Commentary: The C9orf72 Repeat Expansion Disrupts Nucleocytoplasmic Transport
por: Munteanu, Tudor, et al.
Publicado: (2016)

Synaptopathy Mechanisms in ALS Caused by C9orf72 Repeat Expansion
por: Nishimura, Agnes L., et al.
Publicado: (2021)

Unravelling the clinical spectrum and the role of repeat length in C9ORF72 repeat expansions
por: van der Ende, Emma L., et al.
Publicado: (2021)

C9orf72-Derived Proline:Arginine Poly-Dipeptides Modulate Cytoskeleton and Mechanical Stress Response
por: Shiota, Tomo, et al.
Publicado: (2022)

Abnormal expression of homeobox genes and transthyretin in C9ORF72 expansion carriers
por: Finch, NiCole A., et al.
Publicado: (2017)

Eye movement alterations in presymptomatic C9orf72 expansion gene carriers
por: Behler, Anna, et al.
Publicado: (2021)

Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers
por: Gendron, Tania F., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_a53cm8t2r6hnrtlvuql29tu3p2